2017
DOI: 10.1016/j.ygyno.2017.09.023
|View full text |Cite
|
Sign up to set email alerts
|

Abstract: There is widespread interest in the ERAS® guidelines for gynecologic oncology. • Many clinical departments still struggle with how to initiate their ERAS® program. • These recommendations will help translate the ERAS® guidelines into practice.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
41
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
6
3
1

Relationship

0
10

Authors

Journals

citations
Cited by 69 publications
(42 citation statements)
references
References 31 publications
1
41
0
Order By: Relevance
“…29 The mean hospital stay in our study was shorter than the previous ones as ERAS protocol was strictly followed and patients were mobilized early and discharged. 30 The strength of our study is that it is one of the very few studies conducted in the field of ovarian cancer in Indian population which can guide us further in surgical tolerance in this subset of patients. The study also suffered from a few limitations, small sample size and lesser nodal yield being most important.…”
Section: Discussionmentioning
confidence: 96%
“…29 The mean hospital stay in our study was shorter than the previous ones as ERAS protocol was strictly followed and patients were mobilized early and discharged. 30 The strength of our study is that it is one of the very few studies conducted in the field of ovarian cancer in Indian population which can guide us further in surgical tolerance in this subset of patients. The study also suffered from a few limitations, small sample size and lesser nodal yield being most important.…”
Section: Discussionmentioning
confidence: 96%
“…In their study, deviations were mainly justified by medical necessity rather than real non-compliance. Nelson et al 25 have developed practical aspects of running an ERAS protocol within gynecologic oncology, and specific guidelines for gynecologic oncologic surgery 1 2. These two studies offering a chart to peri-operative optimal patient care in gynecology, based on the best available evidence.…”
Section: Discussionmentioning
confidence: 99%
“…As part of the gynecologic oncology ERAS protocol, all patients were given pre-operative acetaminophen (1 g) and ibuprofen (400 mg) or celecoxib (400 mg). Post-operatively, all patients were given acetaminophen (1 g every 6 hours) and ibuprofen (400 mg every 6 hours) scheduled regularly for 48 hours, followed by administration on an ‘as needed’ basis, if they had no contraindications to either medication 20…”
Section: Methodsmentioning
confidence: 99%